Respira Global Inc. is the exclusive North American distributor of HypoxBreath® Advanced, a European Union Class IIa certified medical device delivering precision-guided Intermittent Hypoxia-Hyperoxia Therapy (IHHT). We support the integration of advanced breath training into wellness, clinical, and performance environments across North America.
Developed and regulated in the EU, HypoxBreath® is engineered to facilitate adaptive respiratory patterns using alternating oxygen protocols, real-time heart rate variability (HRV) biofeedback, and automated safety thresholds. It is utilized globally in applications focused on stress modulation, recovery, and physical resilience.
Respira Global does not make specific therapeutic or medical claims and adheres to applicable regulatory frameworks in the United States. Our role is to provide access to sophisticated, non-invasive technology that supports professionals operating within their own scopes of practice.
We serve healthcare practitioners, performance specialists, and wellness providers seeking to incorporate structured respiratory training systems rooted in biofeedback, individualized protocols, and emerging physiological science.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2024
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Respira Global Inc. founded?
Respira Global Inc. was founded in 2024.
What industry is Respira Global Inc. in?
Respira Global Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Respira Global Inc. based?
Respira Global Inc. is headquartered in Kansas City, United States.
Find investors for your startup like Respira Global Inc.
Gritt sends AI-personalised outreach to each investor — from your Gmail
